{
    "2021-05-06": [
        [
            {
                "time": "2021-Q1",
                "original_text": "血制品批签发数据跟踪报告：批签发同比下降 主要品种供给明显下滑",
                "features": {
                    "keywords": [
                        "血制品",
                        "批签发",
                        "同比下降",
                        "供给下滑"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-Q1",
                "original_text": "医药行业2020年年报及2021年一季报总结：Q1业绩复苏回暖 看好CXO、疫苗、创新器械和服务等高景气板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年报",
                        "一季报",
                        "业绩复苏",
                        "CXO",
                        "疫苗",
                        "创新器械",
                        "服务",
                        "高景气板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO",
                        "疫苗",
                        "医疗器械",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021",
                "original_text": "5000亿医药巨无霸现身！国药集团家底好惊人",
                "features": {
                    "keywords": [
                        "医药",
                        "国药集团",
                        "巨无霸"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-Q1",
                "original_text": "天坛生物(600161)：Q1业绩略超预期 规模化优势有望进一步扩大",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "Q1业绩",
                        "略超预期",
                        "规模化优势",
                        "扩大"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-Q1",
                "original_text": "天坛生物(600161)2020年年报及2021年一季报点评：2021Q1业绩恢复略超预期 国内血制品龙头再扬帆",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "年报",
                        "一季报",
                        "Q1业绩",
                        "恢复",
                        "略超预期",
                        "血制品",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}